Valuation: Genpharmasec Limited

Market Cap 626M 6.52M 5.65M 5.34M 4.84M 9.08M 9.15M 63.76M 24.53M 317M 24.5M 23.96M 1.01B P/E 2025
94.5x
P/E 2026 26.9x
Enterprise Value 874M 9.12M 7.9M 7.47M 6.76M 12.69M 12.78M 89.1M 34.28M 443M 34.24M 33.48M 1.41B EV / Sales 2025
2.96x
EV / Sales 2026 0.49x
Free-Float
54.91%
Yield 2025 *
-
Yield 2026 -
1 day-3.42%
1 month+10.78%
3 months-0.88%
6 months+2.73%
Current year-13.74%
1 week 1.1
Extreme 1.1
1.22
1 month 0.9
Extreme 0.9
1.36
Current year 0.75
Extreme 0.75
1.45
1 year 0.75
Extreme 0.75
2.15
3 years 0.75
Extreme 0.75
8.71
5 years 0.75
Extreme 0.75
11.08
10 years 0.75
Extreme 0.75
18
Manager TitleAgeSince
Director of Finance/CFO 39 01/11/2022
Compliance Officer - 27/03/2024
Director TitleAgeSince
Director/Board Member 57 02/01/2019
Director/Board Member 58 02/01/2019
Director/Board Member - 01/11/2022
Change 5-day change 1-year change 3-year change Capi.($)
-3.42%0.00%-41.45%-71.46% 6.76M
-0.89%-3.26%-22.27%+0.33% 178B
+0.80%+2.04%+0.90%+15.29% 120B
-1.14%-0.67%+10.68%+80.89% 62.25B
-0.45%-7.52%+5.36%+36.49% 48.54B
+1.66%+3.81%+0.10%-29.51% 49.82B
+2.54%+2.42%+14.55%-10.15% 31.95B
-0.98%-8.33% - - 28.59B
+4.24%+8.99%+42.94%-6.61% 25B
-0.88%-5.52%-13.43%+3.39% 21.59B
Average +0.14%-3.86%-0.29%+2.07% 56.61B
Weighted average by Cap. +0.11%-3.32%-3.14%+12.68%

Financials

2025 2026
Net sales 337M 3.52M 3.05M 2.88M 2.61M 4.89M 4.93M 34.36M 13.22M 171M 13.2M 12.91M 545M 1.4B 14.59M 12.64M 11.95M 10.82M 20.3M 20.46M 143M 54.86M 710M 54.8M 53.58M 2.26B
Net income 12.31M 128K 111K 105K 95.18K 179K 180K 1.25M 483K 6.24M 482K 471K 19.91M 16.04M 167K 145K 137K 124K 233K 234K 1.63M 629K 8.13M 628K 614K 25.93M
Net Debt -9.4M -98.02K -84.91K -80.29K -72.69K -136K -137K -958K -369K -4.77M -368K -360K -15.21M 249M 2.59M 2.25M 2.12M 1.92M 3.61M 3.64M 25.34M 9.75M 126M 9.74M 9.52M 402M
Logo Genpharmasec Limited
Genpharmasec Limited is an India-based company, which is engaged in the distribution of diagnostic pharma equipment and trading of securities. The Company’s segments include Pharmaceuticals, Trading in Securities, and Laboratory Testing. The Trading in Securities segment invests in the secondary securities market. The Company holds rights to the distribution of equipment, such as i-STAT Analyzers and its Cartridges, manufactured by Abbott Point of Care, USA, all over India. The i-STAT Analyzer is a blood analyzer used in Intensive Care Units (ICUs) of hospitals and provides test results in approximately 10 minutes. The Company’s wholly owned subsidiary includes M/s. Clinigenome India Private Limited.
Employees
13
Date Price Change Volume
15/09/26 1.130 -3.42% 270,928
11/09/26 ₹1.170 +0.86% 514,801
10/09/26 ₹1.160 +3.57% 432,751
09/09/26 ₹1.120 -2.61% 431,683
08/09/26 ₹1.150 +1.77% 499,448
  1. Stock Market
  2. Stocks
  3. ADIRASA Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!